Seeking Alpha

Ono Announces Results of Tender Offer to Acquire Deciphera Pharmaceuticals and Completion of Acquisition of Deciphera (a Wholly Owned Subsidiary of Ono)

OSAKA, Japan and WALTHAM, Mass., June 11, 2024 /PRNewswire/ -- Ono Pharmaceutical, Co., Ltd. (Chairman and CEO: Gyo Sagara, "Ono") today announced that it has successfully completed the tender offer, ...
Seeking Alpha

ONO Enters into a Definitive Agreement to Acquire Deciphera Pharmaceuticals

ONO, as a Global Specialty Pharma company, is committed to delivering innovative new drugs to patients around the world. As a part of our medium-term management plan, ONO aims to reinforce our ...
Business Insider

Deciphera Pharmaceuticals (DCPH) was downgraded to a Hold Rating at JMP Securities

Deciphera Pharmaceuticals (DCPH – Research Report) received a Hold rating and price target from JMP Securities analyst Reni Benjamin today. The company’s shares opened today at $25.20. According to ...
BioWorld

Deciphera says o-yes to $2.4B Ono acquisition

In a $2.4 billion deal, Deciphera Pharmaceuticals Inc. is merging with Ono Pharmaceutical Co. Ltd. Ono is acquiring all of Deciphera’s outstanding stock shares for $25.60 each in cash. The merger ...
Nasdaq

Deciphera Pharmaceuticals Announces Closing of Public Offering of Common Stock

WALTHAM, Mass.--(BUSINESS WIRE)-- Deciphera Pharmaceuticals, Inc. (Nasdaq:DCPH), a clinical-stage biopharmaceutical company focused on addressing key mechanisms of tumor drug resistance, today ...
Nasdaq

The Zacks Analyst Blog Highlights Gilead Sciences, GSK, Deciphera, Bristol Myers and Editas Medicine

It was a busy week in the biotech sector with earnings reports from bigwigs Gilead Sciences, Inc. and GSK plc. Mergers and acquisitions continue to be in the spotlight as pharma and biotech majors ...